Boxer Capital as of March 31, 2024
Portfolio Holdings for Boxer Capital
Boxer Capital holds 59 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Springworks Therapeutics (SWTX) | 8.3 | $168M | 3.4M | 49.22 | |
Cytokinetics Com New (CYTK) | 7.3 | $147M | 2.1M | 70.11 | |
Revolution Medicines (RVMD) | 6.8 | $138M | 4.3M | 32.23 | |
Tyra Biosciences (TYRA) | 5.2 | $106M | 6.4M | 16.40 | |
Apellis Pharmaceuticals (APLS) | 5.0 | $102M | 1.7M | 58.78 | |
Ideaya Biosciences (IDYA) | 4.8 | $97M | 2.2M | 43.88 | |
Merus N V (MRUS) | 4.2 | $86M | 1.9M | 45.03 | |
Sarepta Therapeutics (SRPT) | 4.2 | $84M | 650k | 129.46 | |
Nuvalent Inc-a (NUVL) | 4.2 | $84M | 1.1M | 75.09 | |
BeiGene Sponsored Adr (BGNE) | 3.9 | $78M | 500k | 156.39 | |
Tango Therapeutics (TNGX) | 3.2 | $65M | 8.2M | 7.94 | |
Nkarta (NKTX) | 3.0 | $61M | 5.6M | 10.81 | |
Fate Therapeutics (FATE) | 3.0 | $60M | 8.2M | 7.34 | |
Avidity Biosciences Ord (RNA) | 2.2 | $44M | 1.7M | 25.52 | |
Akero Therapeutics (AKRO) | 2.1 | $42M | 1.7M | 25.26 | |
Rocket Pharmaceuticals (RCKT) | 2.0 | $40M | 1.5M | 26.94 | |
Argenx SE Sponsored Adr (ARGX) | 1.9 | $39M | 100k | 393.72 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 1.7 | $34M | 600k | 56.09 | |
Axsome Therapeutics (AXSM) | 1.6 | $32M | 400k | 79.80 | |
Arcus Biosciences Incorporated (RCUS) | 1.5 | $30M | 1.6M | 18.88 | |
Anaptysbio Inc Common (ANAB) | 1.4 | $29M | 1.3M | 22.52 | |
Immunovant (IMVT) | 1.3 | $27M | 825k | 32.31 | |
Xenon Pharmaceuticals (XENE) | 1.3 | $26M | 600k | 43.05 | |
Arvinas Ord (ARVN) | 1.2 | $25M | 609k | 41.28 | |
Iteos Therapeutics (ITOS) | 1.2 | $25M | 1.8M | 13.64 | |
Viking Therapeutics (VKTX) | 1.2 | $25M | 300k | 82.00 | |
Oric Pharmaceuticals (ORIC) | 1.2 | $24M | 1.7M | 13.75 | |
Kura Oncology (KURA) | 1.1 | $21M | 1.0M | 21.33 | |
Geron Corporation (GERN) | 1.0 | $20M | 6.0M | 3.30 | |
Day One Biopharmaceuticals I (DAWN) | 1.0 | $20M | 1.2M | 16.52 | |
Third Harmonic Bio (THRD) | 0.9 | $19M | 2.0M | 9.44 | |
Kalvista Pharmaceuticals (KALV) | 0.9 | $19M | 1.6M | 11.86 | |
Allogene Therapeutics (ALLO) | 0.8 | $17M | 3.9M | 4.47 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.8 | $17M | 400k | 42.86 | |
Prothena Corp SHS (PRTA) | 0.8 | $17M | 690k | 24.77 | |
Sana Biotechnology (SANA) | 0.8 | $16M | 1.5M | 10.00 | |
Relay Therapeutics (RLAY) | 0.7 | $15M | 1.8M | 8.30 | |
Poseida Therapeutics I (PSTX) | 0.7 | $14M | 4.5M | 3.19 | |
Engene Holdings (ENGN) | 0.6 | $12M | 728k | 16.95 | |
Prelude Therapeutics (PRLD) | 0.6 | $12M | 2.6M | 4.74 | |
Enliven Therapeutics (ELVN) | 0.6 | $12M | 671k | 17.59 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $11M | 750k | 14.82 | |
Jasper Therapeutics Com New (JSPR) | 0.5 | $10M | 350k | 29.36 | |
Boundless Bio (BOLD) | 0.5 | $10M | 711k | 14.25 | |
Spyre Therapeutics Com New (SYRE) | 0.5 | $9.5M | 250k | 37.93 | |
Century Therapeutics (IPSC) | 0.4 | $7.3M | 1.8M | 4.18 | |
Zentalis Pharmaceuticals (ZNTL) | 0.4 | $7.1M | 450k | 15.76 | |
Amylyx Pharmaceuticals (AMLX) | 0.2 | $4.3M | 1.5M | 2.84 | |
Absci Corp (ABSI) | 0.2 | $4.0M | 700k | 5.68 | |
Atara Biotherapeutics (ATRA) | 0.1 | $2.9M | 4.2M | 0.69 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $2.6M | 506k | 5.07 | |
Direxion SHS ETF TR Daily S&p Biotec (LABD) | 0.1 | $2.6M | 350k | 7.29 | |
Bioatla (BCAB) | 0.1 | $2.4M | 686k | 3.44 | |
Health Sciences Acq Corp 2 (OBIO) | 0.1 | $1.3M | 238k | 5.27 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $839k | 209k | 4.01 | |
Milestone Pharmaceuticals (MIST) | 0.0 | $553k | 309k | 1.79 | |
DBV Technologies S A Sponsored Adr | 0.0 | $375k | 500k | 0.75 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $81k | 267k | 0.30 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.2k | 67k | 0.03 |